Ignite Creation Date:
2024-05-06 @ 8:26 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02732119
Status:
COMPLETED
Last Update Posted:
2021-05-05
First Post:
2016-04-04
Brief Title:
Study of Ribociclib With Everolimus Exemestane in HR HER2- Locally AdvancedMetastatic Breast Cancer Post Progression on CDK 46 Inhibitor
Sponsor:
Organization:
Novartis